Catalyst Wire Dossier Catalyst Wire Dossier

Gemzar (gemcitabine)

gemcitabine · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Gemzar (gemcitabine), covering 2009-08-10 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]

See pricing